TYBR Health
PrivateLast Round
Series A
Jul 21, 2026
Est. Valuation
$66M
Total Funding Raised
$39.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TYBR Health is a medical device and regenerative medicine company that develops bioresorbable hydrogel solutions to improve post-operative recovery by protecting healing tissues and preventing internal scarring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TYBR Health Comparables
Compare TYBR Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Betatech Medical | 77% | |
| MAST Biosurgery AG | 77% | |
| Integra LifeSciences Holdings Corporation | 77% |
TYBR Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 21, 2026 | ||||
| Seed | Nov 26, 2025 | ||||
| Seed | Jan 31, 2025 | ||||
| Accelerator | May 29, 2024 | ||||
| Accelerator | Mar 29, 2022 | ||||
Grant | Aug 11, 2021 |
Key People
Founding team and executive leadership
TYBR Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mutual Capital Partners | Series A |
| Plug and Play Tech Center | Seed |
| MedTech Innovator | Seed, Accelerator |
| Vensana Capital | Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Asymmetry Ventures | Seed, Accelerator |
| Texas Medical Center | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 47% QoQ, from 15 to 22 employees.
- Jul 21, 2026
$30M round led by Mutual Capital Partners and Vensana Capital.
Recent news
Latest coverage and updates
- launchesJul 22, 2026
TYBR Health, Inc. launched B3 GEL on Jan 1st '26.
- receives_financingJul 21, 2026
TYBR Health, Inc. was planning to receive financing of $30M in Series A on Jul 21st '26.
- hiresJul 21, 2026
TYBR Health, Inc. hired Greg Banker as Board of Directors on Jul 21st '26.
- hiresJul 21, 2026
TYBR Health, Inc. hired Liz Todia Zambory as Board of Directors on Jul 21st '26.
- receives_financingJul 21, 2026
TYBR Health, Inc. received financing of $30M in Series A on Jul 21st '26.
TYBR Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TYBR Health's valuation, stock price, and market status.
Is TYBR Health a public or private company?
TYBR Health is a private company.
What is the current stock price of TYBR Health?
TYBR Health is a private company with no public stock price. No recent secondary market data is available.
How much is TYBR Health worth (valuation)?
TYBR Health's valuation is estimated at $17.0M based on funding round data.
Can I buy TYBR Health stock?
TYBR Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TYBR Health's last funding round?
TYBR Health's most recent funding round was Seed on January 31, 2025.
Who are the main investors in TYBR Health?
Key investors in TYBR Health include MedTech Innovator, Asymmetry Ventures, Y Combinator, VentureSouq, Mayo Clinic Ventures.
Will TYBR Health IPO soon?
No public IPO plans have been announced for TYBR Health.
How can I track TYBR Health secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TYBR Health's secondary market activity and sign up for updates.